Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
Li Min,
Gao Xiaoyuan,
Wang Huiyun,
Zhang Mingli,
Li Xiaoying,
Wang Shuya,
Wang Shaoqin,
Cao Chongfeng,
Li Ying,
Su Guohai
Affiliations
Li Min
Department of Emergency, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250100, China
Gao Xiaoyuan
Department of Cardiovascular Medicine, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250100, China
Wang Huiyun
Research Center of Translational Medicine, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250100, China
Zhang Mingli
Department of Emergency, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250100, China
Li Xiaoying
Department of Emergency, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250100, China
Wang Shuya
Department of Cardiovascular Medicine, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250100, China
Wang Shaoqin
Department of Emergency, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250100, China
Cao Chongfeng
Department of Intensive Care Unit, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250100, China
Li Ying
Research Center of Translational Medicine, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, No. 105 Jiefang Road, Lixia District, Shandong Province, Jinan 250100, China
Su Guohai
Department of Cardiovascular Medicine, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, No. 105 Jiefang Road, Lixia District, Shandong Province, Jinan 250100, China
Heart failure (HF) is a serious and advanced stage of various cardiac diseases with high mortality and rehospitalization rates. Phosphoglycerate mutase 2 (PGAM2) overexpression was identified in the serum of patients with HF.
